Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer

Cancer Lett. 2017 Aug 10:401:39-45. doi: 10.1016/j.canlet.2017.05.002. Epub 2017 May 17.

Abstract

One of the most important metabolic hallmarks of cancer cells is deregulation of lipid metabolism. In addition, enhancing de novo fatty acid (FA) synthesis, increasing lipid uptake and lipolysis have also been considered as means of FA acquisition in cancer cells. FAs are involved in various aspects of tumourigenesis and tumour progression. Therefore, targeting lipid metabolism is a promising therapeutic strategy for human cancer. Recent studies have shown that reprogramming lipid metabolism plays important roles in providing energy, macromolecules for membrane synthesis, and lipid signals during cancer progression. Moreover, accumulation of lipid droplets in cancer cells acts as a pivotal adaptive response to harmful conditions. Here, we provide a brief review of the crucial roles of FA metabolism in cancer development, and place emphasis on FA origin, utilization and storage in cancer cells. Understanding the regulation of lipid metabolism in cancer cells has important implications for exploring a new therapeutic strategy for management and treatment of cancer.

Keywords: Cancer therapy; Fatty acid; Lipid droplet; Lipid metabolism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Energy Metabolism / drug effects*
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Lipid Droplets / drug effects
  • Lipid Droplets / metabolism
  • Lipid Metabolism / drug effects*
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Signal Transduction / drug effects
  • Tumor Microenvironment

Substances

  • Antineoplastic Agents
  • Hypolipidemic Agents